RecruitingNCT06994182

Perspectives of Italian Employers Regarding the Return to Work Process of Employees Who Received a Cancer Diagnosis: a Qualitative Study


Sponsor

Azienda USL Reggio Emilia - IRCCS

Enrollment

30 participants

Start Date

Apr 1, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

European Cancer Mission calls attention to the return to work (RTW) of cancer survivors (CSs), as one of the pivotal issues of the cancer continuum that need to be addressed through proper and prompt actions and recommendations. Employers are important stakeholders, as they can provide emotional and practical support, sustain communication during the entire process, and guarantee a gradual work reintegration. In Italy there is lack of knowledge regarding this topic. Thus, further exploration of Italian employers' perspectives on the RTW of employees with cancer should be performed to comprehend their unknown experiences. The aim is to explore the perspectives of employers who dealt with the RTW process of employees who received a cancer diagnosis through a qualitative research design.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • employers* of a company
  • being directly involved in managing the RTW process of at least one employee with cancer diagnosis in the last 5 years.
  • An employer can be the specific person who represents the company where the employee was working at the time of cancer diagnosis or a person who supported the employee during the sickness absence and the RTW process (e.g., line manager, human resource manager).

Exclusion Criteria1

  • none

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Azienda USL IRCCS di Reggio Emilia

Reggio Emilia, RE, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06994182


Related Trials